Alexander Zhavoronkov, PhD, is the CEO of Insilico Medicine, Inc, a Baltimore-based company applying the latest advances in artificial intelligence to drug discovery, biomarker development, and ageing research. He is the Chief Scientific Officer of the Biogerontology Research Foundation, a UK-based registered charity supporting ageing research worldwide.
LinkedIn